Prostate cancer is a serious health concern for men, but the degree of danger depends on the stage of the cancer and the individual case. Early-stage prostate cancer is usually slow-growing and may not cause any symptoms or life-threatening complications. However, if left untreated or undetected, it can progress and spread to other areas of the body, causing more severe symptoms and potentially life-threatening complications.
Advanced stage prostate cancer can cause symptoms such as difficulty urinating, blood in the urine or semen, bone pain, fatigue, and unexplained weight loss. It can also spread to other areas of the body, such as the bones, lymph nodes, and other organs, which can further complicate treatment and reduce the chances of survival.
No surgery or radiation?
A study involving 2,664 men between the ages of 50 and 69 with localized prostate cancer found that men who choose to actively monitor the disease can safely do so without immediate surgery or radiation. Fox News brings the information about the study. After a median range of 15 years, the researchers involved in the study compared the participants with death from prostate cancer and death that occurred from other causes. Out of over 1,600 patients who were followed up on, 45 men lost their lives as a result of prostate cancer, with similar numbers in all three treatment groups. The study revealed no differential effects on cancer-specific mortality noted in relation to baseline PSA level, tumor stage or grade, or risk-stratification score.
Apart from the new study, the good news is that prostate cancer is highly treatable, especially when detected early. Many men with prostate cancer live long and healthy lives with proper treatment and management. Regular prostate cancer screening is recommended for men over 50, or earlier for those with a family history of the disease or other risk factors. It is important for men to discuss their individual risk factors and screening options with their healthcare provider to determine the best course of action.